MedTrace Logo

AHC Ballana Heart Study

NCT05661318 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-05-29

No results posted yet for this study

Summary

This Study is designed to assess CVD incidence, prevalence, progression and related risk factors, including genetic background. It will provide an important base for all cardiovascular research activities in our centre and help in designing future studies and guide policy.

Conditions

  • Genetic Predisposition to Disease

Interventions

OTHER

Risk assessment

Collect clinical, laboratoary and genetics data from the participants after informed consent

Sponsors & Collaborators

  • Magdi Yacoub Heart Foundation

    lead OTHER

Principal Investigators

  • Magdi H Yacoub, FRS OM · Imperial College London, and Magdi Yacoub Heart Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2050-12-31
Completion
2055-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05661318 on ClinicalTrials.gov